Dr Meghan Armstrong, PHARMD - Pharmacist in Merrimack, NH

Dr Meghan Armstrong, PHARMD is a Pharmacist based in Merrimack, New Hampshire. Dr Meghan Armstrong is licensed to practice in New Hampshire (license number PHCY00868) and her current practice location is 456 Daniel Webster Hwy, Merrimack, New Hampshire. She can be reached at her office (for appointments etc.) via phone at (603) 424-1120.

NPI number for Dr Meghan Armstrong is 1144825696 and her current mailing address is 456 Daniel Webster Hwy, Merrimack, New Hampshire. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1144825696.

Contact Information

Dr Meghan Armstrong, PHARMD
456 Daniel Webster Hwy,
Merrimack, NH 03054-3699
(603) 424-1120
Not Available

Healthcare Provider's Profile

Full NameDr Meghan Armstrong
GenderFemale
SpecialityPharmacist
Location456 Daniel Webster Hwy, Merrimack, New Hampshire
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1144825696
  • Provider Enumeration Date: 12/02/2020
  • Last Update Date: 12/02/2020

Medical Identifiers

Medical identifiers for Dr Meghan Armstrong such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1144825696NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist PHCY00868 (New Hampshire)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Meghan Armstrong is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Meghan Armstrong, PHARMD
456 Daniel Webster Hwy,
Merrimack, NH 03054-3699

Ph: (603) 424-1120
Dr Meghan Armstrong, PHARMD
456 Daniel Webster Hwy,
Merrimack, NH 03054-3699

Ph: (603) 424-1120

News Archive

Solution-focused communication by nurses improves control of liquid intake during hemodialysis

The research was conducted over a period of six months with a group of 36 patients in the Hemodialysis Unit of the General University Hospital of Alicante and three nurses who had received training in solution-focused communication.

Study shows effective light-induced inactivation of SARS-CoV-2 with conjugated oligomers and polymers

A new pilot study by US researchers demonstrates an alternative approach to long-lasting disinfection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using cationic phenylene ethynylene polymers and oligomers (i.e., conjugated electrolytes). The paper is currently available on medRxiv* preprint server.

Regado Biosciences announces first successful subcutaneous application of an aptamer

Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Chris Rusconi, PhD, Senior Vice President, Chief Scientific Officer and Steven Zelenkofske, DO, FACC, Senior Vice President , Chief Medical Officer presented an abstract at the American College of Cardiology on Monday, March 15, 2010 in Atlanta, Georgia.

Naturally selected mutations of SARS-CoV-2 easily duplicated in vitro

In a recent and timely paper, currently available on the bioRxiv preprint server, researchers from Israel and France demonstrated how in vitro evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain (RBD) follows contagious mutation spread – but can also generate an efficient infection inhibitor.

TOPS Versalink Spinal System to treat moderate to severe lumbar stenosis

Impliant, Inc., a developer of novel motion-sparing alternatives to traditional spinal fusion surgery, announced today that it conducted the first two implantations of its TOPS VersaLink System, the newest addition to its product portfolio.

Read more News

› Verified 7 days ago


Pharmacist in Merrimack, NH

Gregory Vestal, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 570 Daniel Webster Hwy, Merrimack, NH 03054
Phone: 603-424-4519    
Stephen James Deminico,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 615 Daniel Webster Hwy, Merrimack, NH 03054
Phone: 603-423-9330    Fax: 603-423-9336
Lauren Herrick West, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 570 Daniel Webster Hwy, Merrimack, NH 03054
Phone: 603-424-4519    
Renan Moretta,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 416 Daniel Webster Hwy, Merrimack, NH 03054
Phone: 603-424-4833    Fax: 603-424-4578
Mr. Brad A Valenti, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 7 Continental Blvd, Merrimack, NH 03054
Phone: 603-429-0759    Fax: 603-429-0813
Nancy Delaney,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 456 Daniel Webster Hwy, Merrimack, NH 03054
Phone: 603-424-1120    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.